Aleen

Aleen EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Aleen (ALEN.U.CN) as of Oct 22, 2026 is -295,300.00 CAD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -77,500.00 CAD — a change of 281.03% (lower).

EBITDA

-295,300.00CAD

YoY

281.03%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Aleen is 2025 -295,300.00 CAD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Aleen was 2024 -77,500.00 CAD. It decreases by 281.03% lower compared to the previous year.

The Aleen EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2022
-93,800.00 CAD
Jan 1, 2023
28,100.00 CAD
Jan 1, 2024
-77,500.00 CAD
Jan 1, 2025
-295,300.00 CAD
The Aleen EBITDA history
YEAREBITDAYoY
-295,300.00CAD+281.03%
-77,500.00CAD-375.80%
28,100.00CAD-129.96%
-93,800.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Aleen Stock analysis

What does Aleen do? Aleen Inc generates revenue through its AI-powered health management platform, offering services like the Aleen Symptom Checker for preliminary diagnosis. The company targets individuals seeking self-assessment tools for health symptoms, combining AI analysis with professional medical consultation. Customers use the Aleen Symptom Checker to identify potential health issues and receive guidance on next steps, leveraging the firm's artificial intelligence to interpret personal medical indicators. The platform serves as a comprehensive tool for managing key health metrics, connecting users with healthcare professionals for further evaluation. Aleen Inc's primary product, Aleen Symptom Checker, is designed for end-users who need immediate health insights without visiting a doctor. The service integrates personal health monitoring with professional consultancy, allowing users to input symptoms and receive AI-driven suggestions. The company monetizes this by providing a digital health assessment tool that reduces unnecessary doctor visits through accurate preliminary diagnosis, appealing to health-conscious consumers in the online diagnosis market. The firm operates in the online health management sector, focusing on AI-driven symptom analysis and medical consultancy. Aleen Symptom Checker functions as the core offering, enabling users to assess symptoms and access professional advice. By combining artificial intelligence with medical expertise, Aleen Inc positions itself as a solution for individuals managing their health indicators through a digital platform, targeting users who prefer self-diagnosis tools before seeking professional help. Aleen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Aleen stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Aleen is -295,300.00 CAD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Aleen changed from -77,500.00 CAD to -295,300.00 CAD, representing a 281.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Aleen since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Aleen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Aleen

All Key Metrics — Aleen